This work evaluates the radiation shielding capabilities of the PLA-W composite for MV energy photons emitted by a linear accelerator and the feasibility of manufacturing a clinically-used collimator grid in spatially fractionated radiotherapy (SFRT) using the material extrusion (MEX) 3D printing technique. The PLA-W filament used has a W concentration of 93% w/w and a green density of 7.51 g/cm³, characteristics that make it suitable for this purpose. Relevant parameters such as the density and homogeneity distribution of W in the manufactured samples determine the mass attenuation coefficient, directly affecting the radiation shielding capacities, so different printing parameters were evaluated, such as layer height, deposition speed, nozzle temperature, and infill, to improve the protection performance of the samples. Additionally, physical and mechanical tests were conducted to ensure structural stability and spatial variability over time, which are critical to ensure precise spatial modulation of radiation. Finally, a complete collimator grid measuring 9.3 × 9.3 × 7.1 cm³ (consisting of 39 conical collimators with a diameter of 0.92 cm and center-to-center spacing of 1.42 cm) was manufactured and experimentally evaluated on a clinical linear accelerator to measure the radiation shielding and dosimetric parameters such as mass attenuation coefficient, half-value layer (HVL), dosimetric collimator field size, and inter-collimator transmission using radiochromic films and 2D diode array detectors, obtaining values of 0.04692 cm²/g, 2.138 cm, 1.40 cm, and 15.6%, respectively, for the parameters in the study. This shows the viability of constructing a clinically-used collimator grid through 3D printing.

This work reports an optimized method to experimentally quantify the Gd-nanoparticle dose enhancement generated by electronic brachytherapy. The dose enhancement was evaluated considering energy beams of 50 kVp and 70 kVp, determining the Gd-nanoparticle concentration ranges that would optimize the process for each energy. The evaluation was performed using delaminated radiochromic films and a Poly(methyl methacrylate) (PMMA) phantom covered on one side by a thin 2.5 $\mathsf{\mu }$m Mylar filter acting as an interface between the region with Gd suspension and the radiosensitive film substrate. The results for the 70 kVp beam quality showed dose increments of $6\pm 6\%$, $22\pm 7\%$, and $9\pm 7\%$ at different concentrations of 10, 20, and 30 mg/mL, respectively, verifying the competitive mechanisms of enhancement and attenuation. For the 50 kVp beam quality, no increase in dose was recorded for the concentrations studied, indicating that the major contribution to enhancement is from the K-edge interaction. In order to separate the contributions of attenuation and enhancement to the total dose, measurements were replicated with a 12 $\mathsf{\mu }$m Mylar filter, obtaining a dose enhancement attributable to the K-edge of $29\pm 7\%$ and $34\pm 7\%$ at 20 and 30 mg/mL, respectively, evidencing a significant additional dose proportional to the Gd concentration.

This study evaluates the impact of gadolinium-based contrast agents (Omniscan, Dotarem, and Gadovist) on the performance of PAGAT gel dosimeters using spectrophotometric analysis. Dosimeters were infused with gadolinium at concentrations ranging from 0 to 40 mg/mL and irradiated with a 6 MV photon beam over a dose range of 0–15 Gy. Regarding dosimeter behavior, Dotarem exhibited an enhancement in optical density prior to irradiation due to polymerization reactions between the dosimeter and the contrast agent starting at 10 mg/mL, which compromised optical readings above 20 mg/mL. Omniscan consistently showed 37.7% lower sensitivity than standard PAGAT across all concentrations and dose levels. Conversely, Gadovist enhanced sensitivity by up to 50% at 20 mg/mL, with additional gains at higher concentrations, although accompanied by saturation at lower dose levels. Radiological analysis showed that all tested concentrations maintained mass energy–absorption coefficient differences below 1% and water-equivalence in effective atomic number within 5% at 6 MV. These findings underscore the importance of selecting an appropriate contrast agent to enhance gel dosimeter sensitivity, particularly in low-dose regions where measurement uncertainty increases. Additionally, gadolinium-infused PAGAT gels show strong potential for assessing dose enhancement phenomena. Their sensitivity, threshold behavior, and radiological properties suggest they may be suitable for applications in dose enhancement dosimetry as well as conventional clinical settings.

This study presents a comprehensive dosimetric characterization and commissioning of a grid-type collimator manufactured via 3D printing using PLA-W composite filament, following an international protocol for small-field dosimetry. PLA doped with high concentrations of tungsten (>90% w/w) enables the fabrication of miniaturized collimators (<1 cm) with complex geometries, suitable for non-conventional radiotherapy applications. However, accurate assessment of spatial dose modulation is challenged by penumbra overlap between closely spaced beamlets, limiting the application of conventional instrumentation and protocols. To address this, absolute and relative dose distributions were evaluated for various radiation field configurations (number of beamlets) in both lateral and depth directions. Measurements were performed according to the IAEA TRS-483 protocol, using micro-ionization chambers and diode detectors. Additionally, long-term stability assessments were carried out to evaluate both the structural integrity and modulation performance of the printed grid over time. Point dose measurements using the same detectors were repeated after one year, and 2D surface dose distributions measured with EBT3 films were compared to SRS MapCHECK measurements two years later. The generated radiation field size of the central beamlet (FWHM) differed by less than 0.2% (15.8 mm) from the physical projection size (15.6 mm) and the lateral transmission due simultaneous beamlets resulted in FWHM variations of less than 3.8%, confirming manufacturing precision and collimator capability. Output factor measurements increased with the number of beamlets, from 0.75 for a single beamlet to 0.82 for the full beamlets configuration. No significant changes were observed in the depth of maximum dose across the different beamlets configurations (1.20 ± 0.20 cm). On the other hand, the long-term evaluations show no relevant changes in the FWHM or VPR, confirming the performance and reliability of the system. These results support the clinical feasibility and lasting performance stability of in-house manufactured grid collimators using PLA-W filaments and accessible 3D printing technology.

Gadolinium-doped polymer gel dosimeters enable experimental evaluation of dose enhancement in low-energy radiotherapy, although the high Gd concentrations required substantially alter their magnetic relaxation properties, making the optimal Magnetic Resonance Imaging (MRI) readout uncertain. This study characterized the dosimetric response of PAGAT and Gd-PAGAT (9 mg/mL Gd) irradiated with a 150 kVp X-ray beam from 1 to 10 Gy using quantitative 1.5 T MRI. Quantitative R₁ and R₂ maps were obtained from variable flip-angle spoiled gradient echo (SPGR) and multi-echo spin echo (MSE) sequences, respectively, and validated by UV-Vis spectrophotometry. R₁ showed no significant dose dependence in Gd-PAGAT because of severe T₁ shortening. In contrast, R₂ exhibited a robust response, with second-order polynomial fits (R² = 0.9984 for PAGAT and 0.9969 for Gd-PAGAT) and linear behavior between 1 and 7 Gy. The dose sensitivity of Gd-PAGAT was 2.84 ± 0.19 times higher than that of PAGAT (0.5328 vs. 0.1949 s⁻¹·Gy⁻¹). Spectrophotometry confirmed the PAGAT calibration but showed markedly lower sensitivity for Gd-PAGAT, particularly at low doses. These findings demonstrate that R₂ mapping overcomes the limitations imposed by extreme T₁ shortening, extending the applicability of Gd-PAGAT dosimeters for three-dimensional dose enhancement studies in low-energy radiotherapy.